Pharmafile Logo

Telehealth Research

December 1, 2016 | blogs, telehealth 

The remote exchange of data between patients and their clinician

Technology is helping patients become more engaged in managing their own health and manufacturers are keen to leverage these new opportunities in order to improve delivery of care.Smart and ‘telehealth’ devices facilitate the remote exchange of data between a patient at home and their clinician to assist in diagnosis. Telehealth services are being used by more and more patients with chronic diseases such as asthma, COPD, diabetes and cardiovascular disease. In 2014 13% of patients in the UK reported that they used smart phones and apps to monitor their health. 

Read the blog: http://www.researchpartnership.com/news/2016/11/blog-telehealth-research/

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

PEGASUS PHARMA TEAM GOES FROM STRENGTH TO STRENGTH WITH NEW APPOINTMENTS AND SENIOR PROMOTIONS

Growth trend continues at Pegasus with six new appointments and five promotions in the Pharma and Life Sciences team

How published research underpinned a cancer therapy awareness campaign

Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...

Oncology experience & expertise

Did you know 25% of our business is in Oncology?

First, we need to talk: mental healthcare in the MENA region

In our final installment of articles exploring mental health in emerging markets, we take an in-depth look at the situation in the MENA region